University Hospital/Stony Brook ELIH Stony Brook Medicine/Quannacut OP
-
Services:
- No formal relationship with prescribing entity
- Other contracted prescribing entity
- In-network prescribing entity
- Regular outpatient treatment
- Outpatient
- Outpatient methadone/buprenorphine or naltrexone treatment
- Male
- Female
- Mentoring/peer support
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Specially designed program for DUI/DWI clients
- Relapse prevention with naltrexone
- Accepts clients using MAT but prescribed elsewhere
- Prescribes buprenorphine
- Buprenorphine maintenance
- Prescribes naltrexone
- State department of health
- Drug Enforcement Agency (DEA)
- The Joint Commission
- State Substance use treatment agency
- General Hospital (including VA hospital)
- Buprenorphine with naloxone
- Naltrexone (oral)
- Medication for mental disorders
- Buprenorphine without naloxone
- Buprenorphine sub-dermal implant
- Nicotine replacement
- Acamprosate (Campral®)
- Naltrexone (extended-release, injectable)
- Buprenorphine (extended-release, injectable)
- Disulfiram
- Smoking not permitted
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
- Transitional housing, halfway house, or sober home
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- Group counseling
- Substance use disorder education
- Family counseling
- Individual counseling
- Private non-profit organization
- Social skills development
- Integrated primary care services
- Suicide prevention services
- Case management service
- Vaping not permitted
- Adults
- Children/Adolescents
- Screening for substance use
- Screening for tobacco use
- Outreach to persons in the community
- Comprehensive substance use assessment
- Screening for mental disorders
- Complete medical history/physical exam
- Comprehensive mental health assessment
- Drug and alcohol oral fluid testing
- Drug or alcohol urine screening
- Breathalyzer or blood alcohol testing
- Young adults
- Adolescents
- Clients with co-occurring mental and substance use disorders
- Adult women
- Trauma-related counseling
- Anger management
- Cognitive behavioral therapy
- Telemedicine/telehealth therapy
- Relapse prevention
- Brief intervention
- Substance use disorder counseling
- Motivational interviewing
- Medicaid
- Medicare
- Federal, or any government funding for substance use treatment programs
- Cash or self-payment
- IHS/Tribal/Urban (ITU) funds
- Private health insurance
- Discharge Planning
- Outcome follow-up after discharge
- Aftercare/continuing care
- Naloxone and overdose education
- Treatment for gambling disorder
- In-network prescribing entity
- No formal relationship with prescribing entity
- Other contracted prescribing entity
External Opioid Medications Source
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Gender Accepted
Recovery Support Services
Opioid Medications used in Treatment
Exclusive Services
Type of Opioid Treatment
License/Certification/Accreditation
Hospitals
Pharmacotherapies
Facility Smoking Policy
Type of Care
Type of Alcohol Use Disorder Treatment
Education and Counseling Services
Facility Operation (e.g., Private, Public)
Ancillary Services
Facility Vaping Policy
Age Groups Accepted
Assessment/Pre-treatment
Testing
Special Programs/Groups Offered
Treatment Approaches
Payment/Insurance/Funding Accepted
Transitional Services
Other Services
External Source of Medications Used for Alcohol Use Disorder Treatment






